- increased fasting circulating glucose level / IMPC
- decreased total body fat amount / IMPC
- increased lean body mass / IMPC
- decreased circulating alkaline phosphatase level / IMPC
- persistence of hyaloid vascular system / IMPC
- abnormal optic disk morphology / IMPC
- abnormal auditory brainstem response / IMPC
- increased circulating cholesterol level / IMPC
- increased mean corpuscular volume / IMPC
C57BL/6NTac-Cidectm1a(EUCOMM)Wtsi/Cnrm
Status | Available to order |
EMMA ID | EM:04019 |
Citation information | RRID:IMSR_EM:04019 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NTac-Cidectm1a(EUCOMM)Wtsi/Cnrm |
Alternative name | EPD0116_3_D06 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Cidectm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Cidec |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | CNR, Consiglio Nazionale delle Ricerche |
Provider affiliation | EMMA-Monterotondo Campus International Development, CNR, Consiglio Nazionale delle Ricerche |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0116_3_D06. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- CIDEC-related familial partial lipodystrophy / Orphanet_435651
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- decreased white adipose tissue amount / MGI
- no abnormal phenotype detected / MGI
- decreased susceptibility to hepatic steatosis / MGI
- decreased circulating triglyceride level / MGI
- decreased circulating free fatty acid level / MGI
- increased insulin sensitivity / MGI
- abnormal white adipose tissue morphology / MGI
- abnormal brown adipose tissue morphology / MGI
- decreased susceptibility to age related obesity / MGI
- decreased circulating ketone body level / MGI
- increased energy expenditure / MGI
- increased oxygen consumption / MGI
- improved glucose tolerance / MGI
- abnormal fat pad morphology / MGI
- abnormal gonadal fat pad morphology / MGI
- vision/eye phenotype / MGI
- increased body temperature / MGI
- decreased circulating glucose level / MGI
- decreased susceptibility to diet-induced obesity / MGI
- decreased circulating leptin level / MGI
- enhanced lipolysis / MGI
- decreased subcutaneous adipose tissue amount / MGI
- abnormal fat cell morphology / MGI
- decreased gonadal fat pad weight / MGI
- decreased inguinal fat pad weight / MGI
- decreased mesenteric fat pad weight / MGI
- decreased retroperitoneal fat pad weight / MGI
- abnormal blood homeostasis / MGI
- decreased total body fat amount / MGI
- increased respiratory quotient / MGI
- integument phenotype / MGI
- impaired adaptive thermogenesis / MGI
- increased food intake / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).